[go: up one dir, main page]

WO2004035759A3 - Oligonucleotides inhibiteurs cibles sur la metalloproteinase-9 matricielle - Google Patents

Oligonucleotides inhibiteurs cibles sur la metalloproteinase-9 matricielle Download PDF

Info

Publication number
WO2004035759A3
WO2004035759A3 PCT/US2003/033141 US0333141W WO2004035759A3 WO 2004035759 A3 WO2004035759 A3 WO 2004035759A3 US 0333141 W US0333141 W US 0333141W WO 2004035759 A3 WO2004035759 A3 WO 2004035759A3
Authority
WO
WIPO (PCT)
Prior art keywords
matrix metalloproteinase
oligonucleotides
inhibitory oligonucleotides
oligonucleotides targeted
inhibitory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/033141
Other languages
English (en)
Other versions
WO2004035759A2 (fr
Inventor
Duane E Ruffner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genta Salus LLC
Original Assignee
Genta Salus LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genta Salus LLC filed Critical Genta Salus LLC
Priority to AU2003287169A priority Critical patent/AU2003287169A1/en
Publication of WO2004035759A2 publication Critical patent/WO2004035759A2/fr
Publication of WO2004035759A3 publication Critical patent/WO2004035759A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des oligonucléotides inhibiteurs qui sont ciblés sur six régions cibles spécifiques se trouvant sur des acides nucléiques codant la métalloprotéine-9 matricielle. Ces oligonucléotides inhibiteurs ont en général une longueur comprise entre environ 8 et environ 50 nucléotides. Les oligonucléotides préférés sont présentés. Les oligonucléotides selon la présente invention peuvent être incorporés dans des compositions telles que des compositions pharmaceutiques et peuvent également être utilisés dans des méthodes d'inhibition de l'expression de la métalloprotéinase-9 matricielle dans une cellule ou dans un tissu.
PCT/US2003/033141 2002-10-18 2003-10-17 Oligonucleotides inhibiteurs cibles sur la metalloproteinase-9 matricielle Ceased WO2004035759A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003287169A AU2003287169A1 (en) 2002-10-18 2003-10-17 Inhibitory oligonucleotides targeted to matrix metalloproteinase-9

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27378302A 2002-10-18 2002-10-18
US10/273,783 2002-10-18

Publications (2)

Publication Number Publication Date
WO2004035759A2 WO2004035759A2 (fr) 2004-04-29
WO2004035759A3 true WO2004035759A3 (fr) 2005-03-31

Family

ID=32106462

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/033141 Ceased WO2004035759A2 (fr) 2002-10-18 2003-10-17 Oligonucleotides inhibiteurs cibles sur la metalloproteinase-9 matricielle

Country Status (2)

Country Link
AU (1) AU2003287169A1 (fr)
WO (1) WO2004035759A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013886A1 (fr) * 1997-09-17 1999-03-25 East Carolina University Acides nucleiques s'hybridant a des cibles multiples, leur preparation, compositions, formulation, trousses et applications

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013886A1 (fr) * 1997-09-17 1999-03-25 East Carolina University Acides nucleiques s'hybridant a des cibles multiples, leur preparation, compositions, formulation, trousses et applications

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BRANCH A.: "A good antisense molecule is hard to find", TIBS, vol. 23, 1998, pages 45 - 50, XP004108000, DOI: doi:10.1016/S0968-0004(97)01155-9 *
JEN ET AL.: "Suppression of gene expression by targeted disruption of messanger RNA: available options and current strategies", STEM CELLS, vol. 18, 2000, pages 307 - 319 *

Also Published As

Publication number Publication date
AU2003287169A1 (en) 2004-05-04
WO2004035759A2 (fr) 2004-04-29
AU2003287169A8 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
WO2003064625A3 (fr) Compositions oligonucleotidiques presentant une efficacite amelioree
DK1470144T3 (da) Oligonukleotider omfattende alternerende segmenter og anvendelser deraf
WO2003064615A3 (fr) Reduction d'amplifications dependantes d'acides nucleiques non vises: amplification de sequences d'acide nucleique repetitif
WO2003008576A3 (fr) Oligonucleotides synthetiques a double brin utilises pour inhiber de façon ciblee l'expression genique
WO2001047944A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
WO2003080807A3 (fr) Compositions et methodes destinees a supprimer l'expression de genes eucaryotes
WO2005089287A3 (fr) Procedes et compositions pour l'inhibition specifique de l'expression genetique par l'arn double brin
WO2004009792A3 (fr) Vecteurs et procedes d'integration d'acide nucleique bases sur des transposons
WO2004096842A3 (fr) Sequences de nucleotides et d'acides amines du virus du sras, et utilisations associees
PT1175489E (pt) Oligonucleotidos contendo uma sequencia antisense estabilizada por uma estrutura secundaria e composicoes farmaceuticas contendo as mesmas
WO2004078941A3 (fr) Modulation de l'expression genetique au moyen d'hybrides adn/arn
WO2000029623A3 (fr) Acides nucleiques contenant des polymorphismes d'un seul nucleotide et utilisations de ces acides nucleiques
WO1998054313A3 (fr) Sequences genomiques d'adn methyltransferase et oligonucleotides antisens
WO2004001013A3 (fr) Inhibition de l'expression genique chez des vertebres a l'aide d'un arn bicatenaire (rnai)
SE9503117L (sv) Ny användning av padlockprober
EP3040423A3 (fr) Micro-arn et ses utilisations
WO2004046327A3 (fr) Oliogonucleotides inhibiteurs diriges sur bcl-2
WO2004035759A3 (fr) Oligonucleotides inhibiteurs cibles sur la metalloproteinase-9 matricielle
WO2004021978A3 (fr) Modulation antisens de l'expression de la molecule endotheliale 1 (esm-1)
WO2001048245A3 (fr) Acides nucleiques contenant des polymorphismes de nucleotides simples, et procedes d'utilisation correspondants
WO2001040521A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
WO2004027062A3 (fr) Correction fonctionnelle de la variante -786c/t du gene enos humain
WO2005007098A3 (fr) Traitement a l'acide nucleique pour stimulation de la reparation des cartilages
EP1248635A4 (fr) Modulation antisens d'expression de la glycogene synthase kinase 3 alpha
WO2003033659A3 (fr) Modulation anti-sens de l'expression de la metalloproteinase 1 de matrice

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP